Heart failure & cardiomyopathies

Up-Titration of Medication in Patients with New-Onset Heart Failure with and Without Atrial Fibrillation

ESC Heart FailPublished Study of patients from a specialized nurse-led heart failure (HF) clinic

Authors' conclusion

In patients with new-onset HF, up-titration to recommended doses of GDMT was similar in patients with and without AF, but was associated with a greater improvement in LVEF in patients with AF.

Study context

Population
Patients with new-onset HF (<3 months) from a specialized nurse-led HF clinic in the Netherlandspatients with new-onset HF
Participants
607 patients
Comparison
Patients with new-onset HF with and without atrial fibrillation (AF)
  • AFn = 187
  • Sinus rhythmn = 420
Outcome
Baseline characteristics: age, ischaemic heart disease, N-terminal B-type natriuretic peptide
Follow-up
Baseline

Main finding

As reported in the abstract

Patients with AF were older, less likely to have ischaemic heart disease and had higher baseline N-terminal B-type natriuretic peptide levels
all P < 0.05

Further findings

LVEF at baseline · similar

P = 0.453

ACEi/ARB prescription · lower in patients with AF

P = 0.038

Use of diuretics · higher in patients with AF

P < 0.001

Up-titration to guideline-recommended target doses · after an up-titration period of 9 months

Beta-blocker

ACEi/ARB

MRA

LVEF improvement of ≥5% and ≥10% after up-titration · more common in patients with AF

≥5%

≥10%

  • Up-titration to guideline-recommended target doses: beta-blocker P = 0.096
  • Up-titration to guideline-recommended target doses: ACEi/ARB P = 0.098
  • Up-titration to guideline-recommended target doses: MRA P = 0.125
  • Left ventricular ejection fraction (LVEF) improvement of ≥5% and ≥10% after up-titration: ≥5%: P = 0.017
  • LVEF improvement of ≥5% and ≥10% after up-titration: ≥10%: P = 0.043

Reasons for not further up-titrating to recommended target doses

Consistent across patients with AF and sinus rhythm

Mortality and HF rehospitalization · 3 years

Achieving target doses of ACEi/ARB and MRA therapies was associated with lower mortality and HF rehospitalization rates in both patients with AF and those in sinus rhythm

Original publication

Up-Titration of Medication in Patients with New-Onset Heart Failure with and Without Atrial Fibrillation. ESC Heart Fail. Published 19 February 2025. doi:10.1002/ehf2.15188

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.